Activity Overview
This online, on-demand virtual symposium brings together renowned experts in advanced non–small cell lung cancer (NSCLC). In this educational program, these experts use real-world scenarios to guide learners through best practices in biomarker testing and the application of current and emerging targeted therapies for advanced NSCLC. A multidisciplinary faculty panel debates therapeutic decision-making, addresses resistance and sequencing strategies, and highlights proactive management of adverse events to support the safe, effective use of these vital agents.
This educational activity is an archive of the live symposium held on February 21, 2026.
Target Audience
These activities are intended for oncologists and other oncology health care professionals interested in the latest advances in the diagnosis, treatment, and management of lung cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Apply best practices for molecular testing to identify actionable mutations in clinical practice
- Evaluate recent data on current and emerging targeted therapies for advanced NSCLC
- Incorporate molecular testing results alongside patient- and disease-specific characteristics to design personalized treatment plans for advanced NSCLC
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here